Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China flag China · Delayed Price · Currency is CNY
40.73
-0.03 (-0.07%)
At close: Feb 13, 2026

SHA:603014 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.010.22
Debt / EBITDA Ratio
0.010.020.010.081.45
Debt / FCF Ratio
0.010.030.190.107.73
Net Debt / Equity Ratio
-0.37-0.20-0.14-0.120.13
Net Debt / EBITDA Ratio
-3.42-1.57-1.00-0.970.86
Net Debt / FCF Ratio
-4.36-2.91-12.82-1.234.52
Asset Turnover
-0.530.540.56-
Inventory Turnover
-2.522.553.21-
Quick Ratio
2.521.591.141.030.61
Current Ratio
3.202.271.821.490.92
Return on Equity (ROE)
-8.37%9.02%7.55%-
Return on Assets (ROA)
-4.52%4.57%3.37%-
Return on Invested Capital (ROIC)
9.75%9.18%9.46%6.94%6.89%
Return on Capital Employed (ROCE)
7.50%8.70%9.20%7.00%9.30%
Payout Ratio
--0.11%5.98%16.44%
Buyback Yield / Dilution
-5.96%--1.76%-3.63%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.